HCA Healthcare Completes $6.5 Billion Senior Notes Offering
Detailed price information for Hca Holdings Inc (HCA-N) from The Globe and Mail including charting and trades.
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Our AI scores Hca Healthcare, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Hca Healthcare, Inc. is a large-cap company with a market capitalization of $103.40B. It ranks number 1 by market capitalization among the 6 Services-General Medical & Surgical Hospitals, NEC issuers in our coverage with a current forecast.
For HCA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 9.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 11.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, HCA included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-General Medical & Surgical Hospitals, NEC peers listed below that report each metric.
| Metric | HCA | Rank |
|---|---|---|
| Market Cap | $103.40B | 1/6 |
| P/E Ratio | 16.43x | 2/5 |
| Dividend Yield | 0.66% | – |
| EPS | $30.13 | – |
| Revenue/Share | $376.75 | – |
| FCF/Share | $28.59 | – |
| Metric | HCA | Rank |
|---|---|---|
| ROA | 10.7% | – |
| Net Margin | 8.6% | 1/5 |
| EBT Margin | 12.5% | 2/6 |
| Tax Rate | 20.6% | – |
| Metric | HCA | Rank |
|---|---|---|
| Current Ratio | 0.82x | 6/6 |
| Quick Ratio | 0.74x | – |
| Working Capital | -$3.56B | 6/6 |
| Metric | HCA | Rank |
|---|---|---|
| Operating Cash Flow | $11.17B | 1/6 |
| Free Cash Flow | $5.97B | 1/5 |
| Capital Spending | -$5.20B | 5/5 |
| OCF Growth YoY | -13.0% | 5/6 |
| FCF Growth YoY | -26.2% | 4/5 |
| FCF/Sales | 7.6% | 2/5 |
| CapEx/Sales | 6.6% | 1/5 |
| Metric | HCA | Rank |
|---|---|---|
| Asset Turnover | 1.24x | 1/5 |
| Receivables Turnover | 6.8x | 3/6 |
| Fixed Assets Turnover | 2.4x | 6/6 |
| Days Sales Outstanding | 53 days | 4/6 |
| Metric | HCA | Rank |
|---|---|---|
| Total Revenue | $78.70B | 1/6 |
| Net Income | $6.78B | 1/5 |
| Metric | HCA | Rank |
|---|---|---|
| Dividends Per Share | $3.26 | – |
| Payout Ratio | 10.8% | – |
| Shares Outstanding | 209M | – |
| Net Income Growth | 6.8% | – |
| EPS Growth | 16.3% | 3/5 |
| Total Current Assets | $16.22B | |
| Cash & Short-term Investments | $908M | |
| Accounts Receivable | $11.51B | |
| Inventory | $1.67B | |
| Total Liabilities | $68.05B | |
| Short-term Debt | $14.68B |
Companies classified under the same SEC industry code as Hca Healthcare, Inc. (Services-General Medical & Surgical Hospitals, NEC): 6 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeDetailed price information for Hca Holdings Inc (HCA-N) from The Globe and Mail including charting and trades.
HCA Healthcare Inc. (NYSE:HCA) reported third-quarter 2026 earnings and revenue above analyst expectations on Tuesday, ...
Detailed price information for Hca Holdings Inc (HCA-N) from The Globe and Mail including charting and trades.
Our AI scores Hca Healthcare, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For HCA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 9.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 11.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Hca Healthcare, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
6 issuers in our coverage, HCA included, share the SEC industry code Services-General Medical & Surgical Hospitals, NEC. The largest are: Tenet Healthcare Corp (THC), Universal Health Services Inc (UHS), Surgery Partners, Inc. (SGRY), Ardent Health, Inc. (ARDT), Community Health Systems Inc (CYH).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.